» Articles » PMID: 23249525

Quinpirole and 8-OH-DPAT Induce Compulsive Checking Behavior in Male Rats by Acting on Different Functional Parts of an OCD Neurocircuit

Overview
Journal Behav Pharmacol
Date 2012 Dec 20
PMID 23249525
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated whether the serotonin 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) can induce compulsive checking in a large open field, as does the dopamine D2/D3 receptor agonist quinpirole. To induce compulsive checking, male rats were exposed to eight injections of either 8-OH-DPAT (1 mg/kg), quinpirole (0.2 mg/kg), or saline. Subsequently, to assess cross-sensitization, rats received an acute challenge of 8-OH-DPAT or quinpirole. The results showed that treatment with 8-OH-DPAT induces compulsive checking and may have a stronger effect on this behavior compared with quinpirole. However, there was no cross-sensitization between 8-OH-DPAT and quinpirole on measures of compulsive checking and locomotion. Moreover, the spatial distribution of locomotor paths in 8-OH-DPAT animals was more confined and invariant than in quinpirole rats; their rate of locomotor sensitization was also faster than that in quinpirole animals. Thus, although 8-OH-DPAT and quinpirole can induce compulsive checking in a large open field, the results suggest that they do so differently. It is suggested that 8-OH-DPAT and quinpirole probably produce compulsive behavior by acting on different parts of a security motivation circuit underlying obsessive-compulsive disorder. Quinpirole may induce compulsive checking behavior by directly driving dopaminergic activity mediating the motivational drive to check. Conversely, 8-OH-DPAT may perpetuate the activated motivational state by inhibiting the serotonergic-negative feedback signals that normally deactivate the obsessive-compulsive disorder circuit.

Citing Articles

A virtual library for behavioral performance in standard conditions-rodent spontaneous activity in an open field during repeated testing and after treatment with drugs or brain lesions.

Szechtman H, Dvorkin-Gheva A, Gomez-Marin A Gigascience. 2022; 11.

PMID: 36261217 PMC: 9581716. DOI: 10.1093/gigascience/giac092.


8-OH-DPAT enhances dopamine D-induced maternal disruption in rats.

Cai Y, Zhang X, Jiang T, Zhong H, Han X, Ma R J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2022; 208(4):467-477.

PMID: 35434766 DOI: 10.1007/s00359-022-01551-4.


Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder.

Gupta R, Mehan S, Sethi P, Prajapati A, Alshammari A, Alharbi M Brain Sci. 2022; 12(3).

PMID: 35326298 PMC: 8946713. DOI: 10.3390/brainsci12030342.


Effects of repeated treatment with the 5-HT and 5-HT agonists (R)-( +)-8-hydroxy-DPAT and CP-94253 on the locomotor activity and axillary temperatures of preweanling rats: evidence of tolerance and behavioral sensitization.

McDougall S, Taylor J, Roe M, Greenwood C Psychopharmacology (Berl). 2021; 239(2):413-427.

PMID: 34816290 DOI: 10.1007/s00213-021-06012-5.


Memantine and Riluzole Exacerbate, Rather Than Ameliorate Behavioral Deficits Induced by 8-OH-DPAT Sensitization in a Spatial Task.

Janikova M, Mainerova K, Vojtechova I, Petrasek T, Svoboda J, Stuchlik A Biomolecules. 2021; 11(7).

PMID: 34356631 PMC: 8301967. DOI: 10.3390/biom11071007.